What Else: 3D systems says the FDA clearance allows dental laboratories to potentially improve the efficiency of denture production. Glidewell, a producer of restorative dental devices, has begun integrating the technology into its production workflow. “We look forward to implementing 3D Systems’ new workflow,” said Glidewell CEO Stephenie Goddard.
Neil McCaffrey, Vice President and General Manager of Dental at 3D Systems, stated that this FDA clearance aligns with the company's broader strategy to expand its digital dentistry portfolio.
3D systems says the solution integrates various elements of the company's hardware, software and materials technology into a streamlined production process.
How To Buy DDD Stock
By now you're likely curious about how to participate in the market for 3D Systems – be it to purchase shares, or even attempt to bet against the company.
In the the case of 3D Systems, which is trading at $2.58 as of publishing time, $100 would buy you 38.76 shares of stock.
According to data from Benzinga Pro, DDD has a 52-week high of $6.85 and a 52-week low of $1.72.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here.
